These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7205575)

  • 21. Ionization-specific analysis of human intestinal absorption.
    Reynolds DP; Lanevskij K; Japertas P; Didziapetris R; Petrauskas A
    J Pharm Sci; 2009 Nov; 98(11):4039-54. PubMed ID: 19360843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative structure-activity relationships. IV. Non-linear dependence of biological activity on hydrophobic character: a new model.
    Kubinyi H
    Arzneimittelforschung; 1976; 26(11):1991-7. PubMed ID: 1037231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative structure-activity relationships. VI. Non-linear dependence of biological activity on hydrophobic character: calculation procedures for bilinear model.
    Kubinyi H; Kehrhahn OH
    Arzneimittelforschung; 1978; 28(4):598-601. PubMed ID: 581935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
    Kotecha J; Shah S; Rathod I; Subbaiah G
    Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-phospholipid interactions. 2. Predicting the sites of drug distribution using n-octanol/water and membrane/water distribution coefficients.
    Barton P; Davis AM; McCarthy DJ; Webborn PJ
    J Pharm Sci; 1997 Sep; 86(9):1034-9. PubMed ID: 9294818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between the hepatic intrinsic clearance or blood cell-plasma partition coefficient in the rabbit and the lipophilicity of basic drugs.
    Ishizaki J; Yokogawa K; Nakashima E; Ichimura F
    J Pharm Pharmacol; 1997 Aug; 49(8):768-72. PubMed ID: 9379353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular weight and therapeutic dose of drug.
    Lien EJ
    J Clin Hosp Pharm; 1982 Jun; 7(2):101-6. PubMed ID: 7107942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An experimentally based approach for predicting skin permeability of chemicals and drugs using a membrane-coated fiber array.
    Xia XR; Baynes RE; Monteiro-Riviere NA; Riviere JE
    Toxicol Appl Pharmacol; 2007 Jun; 221(3):320-8. PubMed ID: 17493652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling of flux through silicone membranes from water.
    Wasdo S; Juntunen J; Devarajan H; Murray T; Nickels D; Singh S; Shanks T; Ulmer K; Sloan KB
    Eur J Pharm Sci; 2008 Aug; 34(4-5):321-32. PubMed ID: 18588972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QSAR analysis of drug excretion into human breast milk.
    Meskin MS; Lien EJ
    J Clin Hosp Pharm; 1985 Sep; 10(3):269-78. PubMed ID: 4066977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro permeation of drugs into porcine hair follicles: is it quantitatively equivalent to permeation into human hair follicles?
    Frum Y; Eccleston GM; Meidan VM
    J Pharm Pharmacol; 2008 Feb; 60(2):145-51. PubMed ID: 18237461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unified model for the corneal permeability of related and diverse compounds with respect to their physicochemical properties.
    Yoshida F; Topliss JG
    J Pharm Sci; 1996 Aug; 85(8):819-23. PubMed ID: 8863270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of membrane permeability evaluated in in vitro analyses to estimate blood-retinal barrier permeability.
    Kubo Y; Fukui E; Akanuma S; Tachikawa M; Hosoya K
    J Pharm Sci; 2012 Jul; 101(7):2596-605. PubMed ID: 22535532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of skin permeability of drugs. I. Comparison with artificial membrane.
    Hatanaka T; Inuma M; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3452-9. PubMed ID: 2092945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients.
    Schoenwald RD; Ward RL
    J Pharm Sci; 1978 Jun; 67(6):786-8. PubMed ID: 660456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.
    Lozoya-Agullo I; Gonzalez-Alvarez I; Zur M; Fine-Shamir N; Cohen Y; Markovic M; Garrigues TM; Dahan A; Gonzalez-Alvarez M; Merino-Sanjuán M; Bermejo M; Avdeef A
    Pharm Res; 2017 Dec; 35(1):2. PubMed ID: 29288412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.